We found that even when the transcatheter mitral valve procedure is successful, having atrial fibrillation at the day of the procedure doubles the risk of death or rehospitalization for heart failure.

Atrial functional mitral regurgitation (AFMR), characterized by normal mitral valve (MV) function and left ventricular function but with atrial dilation and defects in the ring-like structure that ...

NEW YORK, NY—A novel, robotically-made polymer surgical valve has an “acceptable safety” profile and stable hemodynamics through 1 year of follow-up in younger patients with symptomatic mitral valve ...

Polymer Valve's Strong Debut in Mitral Valve Surgery — Innovation in device material opens new chapter for valve therapies ...

Mitral valve prolapse is a minor heart issue where blood can leak backward into the heart. Learn more about the causes, symptoms, and managing the condition.

The TRIA Mitral Valve is made from proprietary LifePolymer material, developed specifically for heart valve use and engineered at a molecular level to be calcium-resistant, biostable and ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular calcification at high surgical risk for open-heart surgery or ineligible ...

"This approval builds on our more than two decades of mitral valve leadership that includes developing first-of-their-kind devices that truly change – and save – people's lives." ...

Background: We present a technique for mitral valve (MV) replacement that preserves the anterior mitral leaflet (AML) using complete chordal-sparing mitral valve replacement (CCS-MVR), which ...

Novel, balloon-assisted anterior mitral leaflet modification shown to be safe and effective for patients undergoing transcatheter mitral valve replacement ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...